Mr. Berman continued, "While we will continue work

Quote:

---

Mr. Berman continued, "While we will continue working with the FDA for an authorized EUA for our GenViro! Covid-19 :15 Swift Kit for both professional and at-home uses, we will not sit on the sidelines while the FDA reviews our game-changing technology, and are proceeding with separate efforts overseas. We have identified and interviewed distribution organizations for International territories including the Russian Federation where we are at the agreement drafting stage, a second territory that includes India, Malaysia, Singapore and Indonesia, also at the agreement drafting stage, and we have begun an interview process for a territory in the EU by talking to a UK based distributor and a group in Denmark associated with a large Euro-based pharma. We also expect to interview several more EU based companies in the next several weeks."

---

Having observed for years KB's previous work with international markets, I was sure this must be happening. KB is too savvy to let this kind of opportunity languish in the hands of bureaucrats who have no skin in the game. It is great to have confirmation that this is happening.

The next thing I expect to hear is that the inventory that must surely be accumulating in KB's living room will suddenly be shipped to the first/highest bidder for a tidy sum. Sometime after that the FDA will get around to approving the EUAs and expect delivery in the USA the next week. But they might have to get in line.

Way to go, Keith! We're rootin' for ya!